Weekly Twitter Roundup

Posted by Dan Vorhaus on April 2, 2010

Each week there are a number of stories and developments that, for one reason or another, don’t find their way into a full-length posting on the Genomics Law Report. Here’s a recap of what I was Tweeting this week @genomicslawyer:

RT @geneticalliance: Register now for Genetic Alliance’s April Webinars! http://bit.ly/Zh553
New GLR Post: More Myriad: Moving Beyond Single Gene Patents: http://bit.ly/9uqbHb
RT @MishaAngrist: My thoughts on the Myriad ruling: http://bit.ly/aqzI1C A bit more on the wsj blog: http://bit.ly/9y8Dfm
RT @NatureNews: Our human genome extravaganza now live http://bit.ly/ckMVI7 Pieces from Collins and Venter, and 3 great features.
Taking Stock After Gene Patents Are Invalidated (Andy Pollack, NY Times): http://nyti.ms/9tmeNe
RT @dgmacarthur: Summary of personal genomics symposium hosted by @DukeIGSP (and starring @MishaAngrist): http://j.mp/aPFWFc
Concise, well-written recap of Myriad/ACLU decision from Ars Technica/@j_timmer: http://bit.ly/97GXsD Link to Ariad SC opinion appropriate
Credit @Duncande for avoiding the “what happens next?” story re: Myriad & thinking creatively about what to *do* next: http://bit.ly/9qRhDW
Author unkown, but the point-do not jump directly from declining sequencing costs to WGS commoditization-is correct: http://bit.ly/9gEwDe
ScienceOnline Interview with @MishaAngrist, by @BoraZ, on cutting out the middelman (& etc.): http://bit.ly/cBNseS
Agree “incontrovertible evidence” is way too strong RT @glynmoody DNA misdirection from our former PM – http://bit.ly/9Z4kW5
More detailed response re: impact of Myriad to non-human biotechnology IP: http://bit.ly/a3SKkW @phylogenomics @carlzimmer @matthewherper
Comments on GLR Myriad/gene patent posts (http://bit.ly/bkLwGm) are now fixed. Sorry for glitch. Comment string at GF is excellent.
Short-sighted. Doubt this will impact short-term RT @GenomeWeb_News: Myriad Shares Fall Following Court Decision: http://bit.ly/bhYqry
Discussion of direct, immediate impact (=minimal): RT @DukeIGSP $MYGN falls in wake of gene patent decision. http://bit.ly/
RT @dgmacarthur Selection of egg donors based on SATs – a glimpse into our reproductive future: http://bit.ly/aoxltQ (via @GenCounsNews)
Pigs Fly: Federal Court Invalidates Myriad’s Patent Claims http://bit.ly/b6rHic Detailed analysis from Genomics Law Report
On point analysis from @markgfh in Times Online re: impact of Myriad ruling for multiplex testing: http://bit.ly/9HOeYJ
What does Myriad/ACLU ruling mean for $MYGN’s business? Analysts: scenario “manageable”; no near-term competition http://bit.ly/cc9Xid
Not b/c of this ruling, but yes. RT @matthewherper $MYGN loss looks pretty far-reaching. Is the one-gene diagnostic model over?
First thoughts on Myriad/ACLU gene patent decision: http://bit.ly/aItlU5 More coming late tonight or tomorrow.
Myriad/ACLU gene patent opinion is online at the Genomics Law Report. http://bit.ly/cEfVlw Analysis forthcoming.
Myriad/ACLU gene patents: have copy of opinion & rumors are true. Appears method & composition patents both invalidated
Myriad/ACLU gene patent litigation: have heard that ruling is out and patents ruled invalid. Attempting to verify.
Most interesting conv. @DukeIGSP symposium was re: access. All agree access req; issue is standards to ensure accuracy, comprehension
DS also commented that right price for personal genomics is “free”. If that’s what will drive uptake, what is the business model? @DukeIGSP
Personal Genomics Symposium @DukeIGSP: interesting to hear Dietrich Stephan talk of “unmasking” genomes in stages; most not until age 21
Agreed. RT @dgmacarthur: Right now, @23andMe translates better than doctors. RT @DukeIGSP: Many ppl do not speak science; translators needed
RT @dgmacarthur Asian genomics is exploding – Korea announces sequencing of 10 genomes: http://bit.ly/c5mEis /via @thinkgenome
The Finnish Gene Atlas http://bit.ly/9WlhBS To be supplemented with WGS data this year. Interesting.